CH
BIIB icon

Canton Hathaway’s Biogen BIIB Stock Holding History

Canton Hathaway’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-500
Closed -$148K – 142
2019
Q4 		$148K Buy
+500
New +$139K 0.08% 95
2019
Q3 		– Sell
-15
Closed -$4K – 209
2019
Q2 		$4K Sell
15
-45
-75% -$10.4K ﹤0.01% 226
2019
Q1 		$14K Buy
+60
New +$18.9K 0.01% 204

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Canton Hathaway's BIIB Position: Q1 2020 in Review

Canton Hathaway sold out of Biogen (BIIB) in Q1 2020, closing a stake of 500 shares — an estimated $148K sold.

Canton Hathaway first reported a position in BIIB in Q1 2019 and held it in 3 quarters. The position peaked at $148K in Q4 2019. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Canton Hathaway reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Canton Hathaway sold 500 Biogen shares in Q1 2020, an estimated $148K.
  • Canton Hathaway first reported a position in Biogen in Q1 2019 and held it in 3 quarters.
  • Canton Hathaway's Biogen position peaked at $148K in Q4 2019.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Canton Hathaway's 13F filing for Q1 2020, filed 6 May 2020.